Abstract: Liposomal multilamellar vesicles suitable for sustained delivery of therapeutic agents to the peritoneal cavity and a method for their formulation are described. The liposomal multilamellar vesicles comprise a phosphatidylcholine having fatty acid side chains of from 12 to 24 carbons in length and have a size of from about 1 micron to about 15 microns in diameter.
Abstract: Ink compositions consisting of small unilamellar or multilamellar vesicles formed from surfactants of anionic, cationic, zwitterionic and nonionic molecules having an oil soluble dye, inclusive of a lipid-soluble dye associated therewith are described. The dye to surfactant ratio is preferably from about 1:1 to about 1:10. The compositions are useful in traditional printing techniques such as flexography and rotogravure and in electronic printing systems such as with an ink-jet printer.
Type:
Grant
Filed:
December 18, 1986
Date of Patent:
November 8, 1988
Assignees:
Xerox Corporation, Vestar, Inc.
Inventors:
Ronald C. Gamble, Micheal C. Hair, Sava R. Lukac, Michael G. Taylor
Abstract: Formulations consisting of phospholipid bilayer membrane particles made from mixtures of anionic and neutral phospholipids encapsulating anthracycline anti-neoplastic agents, suspended in a low ionic strength aqueous phase, are described. In a preferred embodiment, the particles are in the form of vesicles which comprise daunorubicin, distearoyl phosphatidylglycerol and distearoyl phosphatidylcholine, the mol ratio of daunorubicin to distearoyl phosphatidylglycerol is at least about 1:1.25, and the suspending medium is an aqueous lactose solution containing a small amount of base.
Abstract: An agent for contrast enhancement in nuclear magnetic resonance imaging is disclosed. Micellular particles such as phospholipid vesicles are associated with or enclose a paramagnetic material. The particles may be formulated with an agent, such as cholestrol, to promote vesicle stability and water exchange across the vesicle bilayer. The vesicles may or may not have antibodies or other cell recognition targeting agents attached to the surface to provide specific targeting. The vesicles provide enhanced target specificity, reduced burden of toxic contrast material and amplified contrast enhancement.